Jun 2026 (Q2 FY26) — Aug 5, 2026
EverCommerce Q2 FY26 — Revenue in-line, EBITDA beat, CEO transition
Read the full callEverCommerce (EVCM) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
EverCommerce earnings: last reported Wed, 5 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 152 | +2.7% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 11.5 | +0.8 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 9.7 | +19.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$9.53 +1.71% · +$0.16
Performance −13.3% 1Y
1Y: $10.99 on 14 Oct 2025 → $9.53. High $13.4 (16 Dec 2025), low $6.31 (11 Sept 2026).
- Previous close
- $9.37
- 52-week range
- $6.31 – $13.4
- One year
- −14.53%
Overview
- Symbol
- EVCM
- Sector
- Information Technology
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
EverCommerce earnings calls (EVCM)
Financials
What the filings say
Net profit, year on year: +19% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 140 | 175 | 142 | 148 | 147 | 151 | 147 | 152 |
| Expenses | 130 | 187 | 128 | 132 | 132 | 138 | 135 | 135 |
| Operating profit | 10 | -12 | 14 | 16 | 16 | 13 | 13 | 17 |
| Operating margin | 7.3% | −6.8% | 10.0% | 10.7% | 10.8% | 8.8% | 8.5% | 11.5% |
| Other income | -18 | -2 | -13 | -9 | -9 | -8 | -5 | -6 |
| Interest | 11 | 10 | 9 | 9 | 9 | 8 | 8 | 8 |
| Profit before tax | -8 | -14 | 1 | 7 | 7 | 6 | 8 | 11 |
| Tax rate | −11.5% | 11.5% | 35.4% | 17.8% | 17.7% | −0.8% | 8.1% | 13.2% |
| Net profit | -9 | -12 | -8 | 8 | 11 | 6 | 7 | 10 |
| EPS ($ per share) | -0.05 | — | -0.04 | 0.04 | 0.06 | — | 0.04 | 0.05 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Equity capital | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | — | -431 | -513 | -573 | -620 | -661 | -643 |
| Total liabilities | — | 808 | 678 | 685 | 692 | 670 | 655 |
| Fixed assets | — | 15 | 14 | 12 | 10 | 6 | 6 |
| Total assets | — | 1,328 | 1,663 | 1,592 | 1,518 | 1,421 | 1,372 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -1 | 58 | 37 | 65 | 105 | 113 | 111 |
| Cash from investing | -324 | -418 | -380 | -18 | -38 | -12 | -31 |
| Cash from financing | 310 | 402 | 341 | -47 | -67 | -60 | -88 |
| Net cash flow | -15 | 41 | -1 | -2 | 0 | 40 | -6 |
| Capital expenditure | -8 | -5 | -3 | -3 | -3 | -1 | -2 |
| Free cash flow | -8 | 53 | 34 | 62 | 102 | 112 | 109 |
Insider filings
234 filings between Oct 21, 2025 and Oct 1, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$16.84M
162 sales by 4 insiders
81% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 9
- Award — granted as compensation
- 62
- Tax withheld — shares kept back by the company to cover tax
Also filed: 1 other.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Remer Eric Richard | — | $12.32M | Sep 16, 2026 |
| Feierstein Matthew David | — | $3.79M | Oct 1, 2026 |
| Storey Lisa E | — | $419.5K | Aug 22, 2026 |
| Siurek Ryan H | — | $315.0K | Aug 19, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Feierstein Matthew David President | Sale 10b5-1 plan | 10,000 | $100.0K |
| Sep 17, 2026 | Goor Alexander Chief Executive Officer | Award | 422,678 | $0 |
| Sep 17, 2026 | Goor Alexander Chief Executive Officer | Award | 338,142 | $0 |
| Sep 16, 2026 | Remer Eric Richard Director | Sale | 258 | $2.1K |
| Sep 15, 2026 | Remer Eric Richard Director | Sale | 533 | $4.3K |
| Sep 5, 2026 | Siurek Ryan H Chief Financial Officer | Tax withheld | 2,800 | $22.2K |
| Sep 5, 2026 | Feierstein Matthew David President | Tax withheld | 6,604 | $52.3K |
| Sep 5, 2026 | Siurek Ryan H Chief Financial Officer | Tax withheld | 2,606 | $20.6K |
| Sep 5, 2026 | Storey Lisa E Chief Legal Officer | Tax withheld | 1,580 | $12.5K |
| Sep 5, 2026 | Storey Lisa E Chief Legal Officer | Tax withheld | 1,423 | $11.3K |
| Sep 5, 2026 | Feierstein Matthew David President | Tax withheld | 5,773 | $45.7K |
| Sep 4, 2026 | Remer Eric Richard Director | Sale | 2,997 | $24.0K |
| Sep 3, 2026 | Storey Lisa E Chief Legal Officer | Tax withheld | 1,170 | $9.3K |
| Sep 3, 2026 | Feierstein Matthew David President | Tax withheld | 6,484 | $51.4K |
| Sep 3, 2026 | Remer Eric Richard Director | Sale | 6,354 | $51.3K |
| Sep 2, 2026 | Remer Eric Richard Director | Sale | 5,313 | $42.7K |
| Sep 1, 2026 | Remer Eric Richard Director | Sale | 47,353 | $390.1K |
| Aug 31, 2026 | Remer Eric Richard Director | Sale | 40,906 | $364.6K |
| Aug 28, 2026 | Remer Eric Richard Director | Sale | 23,824 | $219.5K |
| Aug 28, 2026 | Remer Eric Richard Director | Tax withheld | 212,227 | $2.25M |
| Aug 27, 2026 | Remer Eric Richard Director | Sale | 8,041 | $74.3K |
| Aug 27, 2026 | Remer Eric Richard Director | Sale | 6,553 | $60.5K |
| Aug 26, 2026 | Remer Eric Richard Director | Sale | 18,316 | $164.2K |
| Aug 26, 2026 | Remer Eric Richard Director | Sale | 3,505 | $31.7K |
| Aug 25, 2026 | Remer Eric Richard Director | Sale | 11,568 | $105.2K |
| Aug 25, 2026 | Remer Eric Richard Director | Sale | 9,142 | $83.9K |
| Aug 24, 2026 | Remer Eric Richard Director | Sale | 13,974 | $133.7K |
| Aug 22, 2026 | Storey Lisa E Chief Legal Officer | Sale | 1,228 | $11.8K |
| Aug 22, 2026 | Siurek Ryan H Chief Financial Officer | Tax withheld | 1,396 | $13.5K |
| Aug 22, 2026 | Feierstein Matthew David President | Tax withheld | 6,604 | $63.7K |
| Aug 21, 2026 | Remer Eric Richard Director | Sale | 16,602 | $159.9K |
| Aug 20, 2026 | Siurek Ryan H Chief Financial Officer | Tax withheld | 606 | $5.9K |
| Aug 20, 2026 | Remer Eric Richard Director | Sale | 26,530 | $259.4K |
| Aug 19, 2026 | Remer Eric Richard Director | Sale | 9,355 | $95.1K |
| Aug 19, 2026 | Remer Eric Richard Director | Sale | 11,558 | $117.6K |
| Aug 19, 2026 | Siurek Ryan H Chief Financial Officer | Sale | 3,188 | $32.4K |
| Aug 18, 2026 | Remer Eric Richard Director | Sale | 9,845 | $98.4K |
| Aug 18, 2026 | Remer Eric Richard Director | Sale | 19,274 | $193.1K |
| Aug 17, 2026 | Siurek Ryan H Chief Financial Officer | Sale | 16,812 | $171.6K |
| Aug 14, 2026 | Siurek Ryan H Chief Financial Officer | Tax withheld | 1,067 | $10.9K |
| Aug 14, 2026 | Remer Eric Richard Director | Sale | 23,947 | $240.1K |
| Aug 14, 2026 | Storey Lisa E Chief Legal Officer | Sale | 17,012 | $170.4K |
| Aug 13, 2026 | Remer Eric Richard Chief Executive Officer | Sale 10b5-1 plan | 17,285 | $172.8K |
| Aug 12, 2026 | Remer Eric Richard Chief Executive Officer | Sale 10b5-1 plan | 22,392 | $221.1K |
| Aug 12, 2026 | Remer Eric Richard Chief Executive Officer | Sale 10b5-1 plan | 2,410 | $23.7K |
| Aug 11, 2026 | Remer Eric Richard Chief Executive Officer | Sale 10b5-1 plan | 8,462 | $83.4K |
| Aug 11, 2026 | Remer Eric Richard Chief Executive Officer | Sale 10b5-1 plan | 16,790 | $166.4K |
| Aug 6, 2026 | Feierstein Matthew David President | Sale 10b5-1 plan | 5,000 | $51.0K |
| Aug 5, 2026 | Remer Eric Richard Chief Executive Officer | Sale 10b5-1 plan | 5,757 | $68.1K |
| Aug 5, 2026 | Feierstein Matthew David President | Sale 10b5-1 plan | 10,000 | $118.3K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for EverCommerce Inc.
Free account. Everything above stays public.
Write why you follow EverCommerce Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading